Göran Rådegran
111 – 120 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Characteristics and survival of adult Swedish PAH and CTEPH patients 2000–2014
(
- Contribution to journal › Article
-
Mark
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial
(
- Contribution to journal › Article
- 2015
-
Mark
Hemodynamic Characteristics Including Pulmonary Hypertension at Rest and During Exercise Before and After Heart Transplantation.
(
- Contribution to journal › Article
-
Mark
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial
(
- Contribution to journal › Article
-
Mark
Outcomes after ABO-incompatible heart transplantation in adults: A registry study.
(
- Contribution to journal › Article
-
Mark
ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients.
(
- Contribution to journal › Article
-
Mark
Mechanical compression during repeated sustained isometric muscle contractions and hyperemic recovery in healthy young males.
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart-transplant patients.
(
- Contribution to journal › Article
-
Mark
Immunosuppressive therapies after heart transplantation - The balance between under- and over-immunosuppression.
(
- Contribution to journal › Article
-
Mark
Pulmonell arteriell hypertension - allvarlig prognos trots stora framsteg.
(
- Contribution to journal › Article